All News

Apomorphine hydrochloride (Kynmobi; Sunovion) is a sublingual therapy for the acute intermittent treatment of off episodes in patients with Parkinson disease.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” on Tuesday, October 13, 2020 at 6 PM EDT.

Rutledge v. Pharmaceutical Care Management Association seeks to clarify whether states can regulate pharmacy benefit managers.

New policy recommendations aim to increase the uptake of biomarker testing and advance health insurance coverage for precision medicine in cancer care.

Every year, Drug Topics® asks pharmacists about their job experiences. Take our 2020 Annual Pharmacy Salary Survey here.

What happens next in health care depends largely on COVID-19, especially in light of the breaking news that the President has been diagnosed with COVID-19. And then, of course, on the 2020 presidential election itself.

Watch some of the highlights from the virtually-held ThoughtSpot 2020 conference and trade show.

SingleCare's "Best of the Best" Pharmacy Awards honors pharmacists and pharmacy technicians, the COVID-19 pandemic's unsung health care heroes.

Tofacitinib (Xeljanz; Pfizer) is the first and only Janus kinase inhibitor approved in the US for this indication.

Members of the MJH Life Sciences COVID-19 Coalition weighed in on the latest pandemic information in a recent survey.

The FDA is requiring an update to the boxed warning on all benzodiazepines and new labeling.

The FDA’s final rule allows the importation of certain prescription drugs from Canada under certain conditions.

Anticipating higher demand for the flu vaccine this season, many pharmacy chains are expanding their services.

The FDA has approved mepolizumab (Nucala; GSK) as the first biologic treatment of hypereosinophilic syndrome.

Dangerous social media challenges prompt the FDA to warn about the serious risks associated with taking excessive doses of diphenhydramine (Benadryl).

Walmart is piloting drone delivery of at-home coronavirus disease 2019 (COVID-19) self-collection kits.

Sun Pharmaceuticals issued a voluntary recall of 1 lot of its metformin hydrochloride for extended-release (ER) oral suspension (Riomet ER), 500 mg per 5 mL.

The US Preventive Services Task Force concluded that the current evidence is insufficient to make a recommendation for or against vitamin D deficiency screening in asymptomatic adults.

Perrigo has issued a voluntary recall of all unexpired albuterol sulfate inhalation aerosol to the retail level.

Two lots of the thyroid tablets are being recalled after testing found the lots to be subpotent.

Community pharmacy owner/manager respondents reported that patients’ prescriptions were transferred without permission.

The Trump administration released its COVID-19 vaccine strategy, with pharmacies among the list of suggested providers for distribution.

Labs and drug stores are making at-home coronavirus disease 2019 (COVID-19) tests more accessible.

Eric Levin, CEO of Scripta Insights, discusses how "positive disruption" from private companies are positioned to confront challenges within the pharmaceutical industry.

The annual event, which convenes thousands of independent community pharmacies, moves to an immersive virtual environment on AmerisourceBergenLive.com

AmerisourceBergen and Good Neighbor Pharmacy (GNP) kicked off the first virtual ThoughtSpot, GNP’s annual independent community pharmacy conference and trade show.

After a temporary pause, investigators have received the green light to resume clinical trials for COVID-19 vaccine candidate AZD1222 following a safety review.

In a partnership with top health care experts, MJH Life Sciences™ COVID-19 Coalition will host its inaugural event, "Battling Dual Threats: Flu and COVID-19 Converge" on Tuesday, September 15, at 6 p.m. EDT.

Albertsons announced its pharmacies will begin to offer vaccinations to children 3 years and older nationwide.

Fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta; GlaxoSmithKline) is indicated for the treatment of asthma in patients aged 18 years and older.